Nyxoah S.A (NYXH) Price to Earnings Ratio

Nyxoah, S.A. - graphic logo of issuer NYXH

Nyxoah S.A. (NYXH) generates revenue through the implementation of neurostimulation systems for apnea therapy, as confirmed by the current market quotes shown below with the -0.90 indicator. The production of hardware components and service support in the US and Europe have been outsourced to third-party contractors. The biotech firm is currently scaling sales, although high personnel costs are temporarily hindering the growth of operational efficiency.

Nyxoah (NYXH) - P/E Multiple from 09/25/2023 to 11/18/2026

Analytical breakdowns for Nyxoah S.A.

- price and consensus price forecast:
General company analysis:Nyxoah SA, NYXH
Product sample of Nyxoah S.A.

For Nyxoah S.A. (NYXH), a fundamental business valuation through the lens of yield is critical as the company scales neurostimulator production in Belgium and Israel. The company's estimated P/E reflects the ratio of market capitalization to net income, demonstrating how much an investor is willing to pay per unit of earnings. This chart allows for a correlation between market expectations and the actual efficiency of innovation implementation in the US and EU. This indicator helps identify asset overvaluation or hidden profitability risks in a timely manner.

Analysis of competing companies

P/E Multiple Intuitive Surgical, Inc.|Price to Earnings Ratio DHR (Danaher Corp)|BDX (Becton, Dickinson and Company) - Company Value to Net Income|P/E Multiple STE (steris.com)|Business Payback Period westpharma.com (WST)|BAX - Price to Earnings Ratio|Business Payback Period Masimo Corp MASI|Stevanato Group S.p.A. (STVN) - Price to Earnings Ratio|TFX - Business Payback Period|Price to Earnings Ratio merit.com|Envista (NVST) - Business Payback Period|Price to Earnings Ratio ICUI (ICU Medical, Inc.)|Market Price to Net Income Ratio XRAY|Price to Earnings Ratio LeMaitre LMAT|Company Value to Net Income ATRC|STAA: Price to Earnings Ratio|NAGE - P/E Multiple|ZimVie Inc (ZIMV) - Price to Earnings Ratio|Price to Earnings Ratio AngioDynamics|CERS (cerus.com) - P/E Multiple|Market Cap to Earnings Teknova Inc TKNO|Price to Earnings Ratio Monogram Orthopedics (MGRM)|Sharps Tech - Price to Earnings Multiple|InfuSystem Holdings, Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio UTMD (Utah Medical Products Inc.)|KRMD - Price to Earnings Ratio|Business Payback Period Microbot Medical, Inc MBOT|Pro-Dex Corp (PDEX) - Price to Earnings Ratio|Market Cap to Net Income ZTEK (Zentek Ltd.)|Price to Earnings Ratio Elutia|Milestone Scientific Inc (MLSS) - Business Payback Period|Price to Earnings Ratio NXGL (NEXGEL, Inc.)|RVP (Retractable Technologies, Inc.) - Company Value to Net Income|Harvard Bioscience, Inc. - Price to Earnings Ratio|P/E Multiple femasys.com FEMY|MHUA: Price to Earnings Ratio|Business Payback Period predictive-oncology.com POAI|Callan JMB Inc (CJMB) - Price to Earnings Ratio|Price to Earnings Multiple ATRI|NURO (NeuroMetrix Inc) - P/E Multiple